Gary Lee

Company: Lyell Immunopharma

Job title: CSO

Seminars:

Rejuvenation of T-Cells Results in Younger Epigenetic Age & Improved Anti-Tumor Functions In Vitro & In Vivo 11:00 am

Novel potential disruptive technology to rejuvenate T-cells across multiple therapeutic modalities Rejuvenated T-cells show younger epigenetic age, enhanced cell proliferation and cytokine release, and sustained antitumor activity in vitro and in vivo Rejuvenated TILs preserve polyclonal anti-tumor TCR repertoire and display improved antitumor propertiesRead more

day: Conference Day Two - Track A - AM